MIAMI, May 01, 2018 -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, updates shareholders that it is no longer on the Regulation SHO watch list with OTCMarkets.
The Company recently began taking action to alleviate pressure caused by naked short positions in the Company’s stock. The Company contacted a number of broker/dealers, clearing firms, and reached out to FINRA’s Division of Market Regulation about the problem naked shorting is causing in the market for the Company’s securities. Management believes this effort of raising awareness within compliance offices has led to a significant decrease in naked short positions in the market, which has resulted in the removal of Progressive Care (OTCQB:RXMD) from the OTCMarkets Regulation SHO watch list for significant fails to deliver. The Company intends to continue contacting broker/dealers and clearing firms to ensure that they are complying with all regulations.
“We are pleased that our efforts have had a positive impact on the stability of the market for our stock,” stated S. Parikh Mars, CEO. "Our shareholders especially have done a tremendous job of contacting their firms to prevent their shares from being borrowed for short positions. We cannot prevent all instances of naked shorts, but we can apply pressure and raise awareness with broker/dealers and clearing firms to be vigilant in their compliance protocols in this regard. We will continue to monitor the situation and take action when necessary now and into the future.”
Get connected and stay in touch with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive Care
Progressive Care Inc. (OTCQB:RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Contact Armen Karapetyan Senior Advisor Business Development [email protected] www.progressivecareus.com www.pharmcopharmacy.com


Supermicro Forecasts Strong Q4 Revenue Growth as AI Server Demand Surges
Orsted Q1 EBITDA Beats Expectations Despite U.S. Impairments
Apple Explores Intel and Samsung Partnerships to Diversify Chip Supply Chain
Hugo Boss Beats Q1 Profit Expectations Despite Market Headwinds
Palantir Reports Record Growth, Raises 2026 Revenue Outlook Above Expectations
Volvo Car Sales Drop 10% in Early 2026 Despite Growth in Electric Vehicles
UOB Q1 Profit Meets Expectations as Loan Growth Offsets Lower Interest Rates
Aker BP Q1 Profit Jumps on Higher Oil Prices and Asset Reversal
Strategy Reports Q1 Loss as Bitcoin Holdings Trigger $14.46 Billion Unrealized Hit
BMW Keeps 2026 Outlook Despite 25% Profit Drop Amid Tariff Pressure
Lufthansa Q1 Loss Narrows as Strong Summer Travel Demand Boosts Outlook
Intel Emerges as Key Contender in Apple’s Chip Manufacturing Strategy Shift
Maersk Q1 Earnings Beat Expectations as Iran Conflict Clouds Shipping Outlook
Hua Hong Semiconductor Stock Surges to Multi-Year High Amid AI Boom
Philips Reaffirms 2026 Outlook After Strong Q1 Sales and Margin Beat
Samsung Surpasses $1 Trillion Market Cap Amid AI Chip Boom and Apple Partnership Talks
Rivian Hints at New R2 Variants as Production Ramps Up Ahead of 2027 Launch 



